In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, ATAI Life Sciences N.V (NASDAQ: ATAI) closed at $1.33 down -6.34% from its previous closing price of $1.42. In other words, the price has decreased by -$6.34 from its previous closing price. On the day, 1.29 million shares were traded. ATAI stock price reached its highest trading level at $1.43 during the session, while it also had its lowest trading level at $1.3.
Ratios:
For a deeper understanding of ATAI Life Sciences N.V’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.81 and its Current Ratio is at 5.81. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 18, 2024, Reiterated its Buy rating but revised its target price to $10 from $15 previously.
On April 03, 2024, Maxim Group Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $6.
On November 01, 2022, Loop Capital started tracking the stock assigning a Buy rating and target price of $18.Loop Capital initiated its Buy rating on November 01, 2022, with a $18 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 26 ’24 when ATAI Life Sciences N.V. sold 2,660,000 shares for $6.05 per share. The transaction valued at 16,093,000 led to the insider holds 6,905,774 shares of the business.
Brand Florian sold 151,303 shares of ATAI for $290,502 on May 16 ’24. The insider now owns 328,697 shares after completing the transaction at $1.92 per share. On Apr 02 ’24, another insider, Johnson Anne Nagengast, who serves as the Chief Financial Officer of the company, sold 27,410 shares for $1.85 each. As a result, the insider received 50,708 and left with 73,590 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATAI now has a Market Capitalization of 223176672 and an Enterprise Value of 152110016. For the stock, the TTM Price-to-Sale (P/S) ratio is 676.30 while its Price-to-Book (P/B) ratio in mrq is 1.53. Its current Enterprise Value per Revenue stands at 459.547 whereas that against EBITDA is -1.485.
Stock Price History:
The Beta on a monthly basis for ATAI is 1.17, which has changed by -0.21111113 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, ATAI has reached a high of $2.85, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is -8.34%, while the 200-Day Moving Average is calculated to be -10.91%.
Shares Statistics:
For the past three months, ATAI has traded an average of 1.69M shares per day and 2422360 over the past ten days. A total of 167.82M shares are outstanding, with a floating share count of 117.06M. Insiders hold about 30.24% of the company’s shares, while institutions hold 7.12% stake in the company. Shares short for ATAI as of 1735603200 were 10743811 with a Short Ratio of 6.34, compared to 1732838400 on 10204988. Therefore, it implies a Short% of Shares Outstanding of 10743811 and a Short% of Float of 8.3900005.
